These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36102916)

  • 1. Antitumor/anti-angiogenesis efficacy of epigallocatechin gallate nanoformulated with antioxidant in melanoma.
    Sudha T; Salaheldin TA; Darwish NH; Mousa SA
    Nanomedicine (Lond); 2022 Jun; 17(15):1039-1053. PubMed ID: 36102916
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets.
    Talib WH; Awajan D; Alqudah A; Alsawwaf R; Althunibat R; Abu AlRoos M; Al Safadi A; Abu Asab S; Hadi RW; Al Kury LT
    Molecules; 2024 Mar; 29(6):. PubMed ID: 38543009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tea-break with epigallocatechin gallate derivatives - Powerful polyphenols of great potential for medicine.
    Bakun P; Mlynarczyk DT; Koczorowski T; Cerbin-Koczorowska M; Piwowarczyk L; Kolasiński E; Stawny M; Kuźmińska J; Jelińska A; Goslinski T
    Eur J Med Chem; 2023 Dec; 261():115820. PubMed ID: 37776575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excellent anti-proliferative and pro-apoptotic effects of (-)-epigallocatechin-3-gallate encapsulated in chitosan nanoparticles on human melanoma cell growth both in vitro and in vivo.
    Siddiqui IA; Bharali DJ; Nihal M; Adhami VM; Khan N; Chamcheu JC; Khan MI; Shabana S; Mousa SA; Mukhtar H
    Nanomedicine; 2014 Nov; 10(8):1619-26. PubMed ID: 24965756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epigallocatechin gallate derivative Y
    Liao ZH; Zhu HQ; Chen YY; Chen RL; Fu LX; Li L; Zhou H; Zhou JL; Liang G
    J Ethnopharmacol; 2020 Sep; 259():112852. PubMed ID: 32278759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice.
    Wang CC; Xu H; Man GC; Zhang T; Chu KO; Chu CY; Cheng JT; Li G; He YX; Qin L; Lau TS; Kwong J; Chan TH
    Angiogenesis; 2013 Jan; 16(1):59-69. PubMed ID: 22948799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (-)-Epigallocatechin-3-gallate and hydroxytyrosol improved antioxidative and anti-inflammatory responses in bovine mammary epithelial cells.
    Basiricò L; Morera P; Dipasquale D; Bernini R; Santi L; Romani A; Lacetera N; Bernabucci U
    Animal; 2019 Dec; 13(12):2847-2856. PubMed ID: 31182175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tea polyphenol epigallocatechin-3-gallate associates with plasma membrane lipid rafts: lipid rafts mediate anti-allergic action of the catechin.
    Tachibana H; Fujimura Y; Yamada K
    Biofactors; 2004; 21(1-4):383-5. PubMed ID: 15630231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-dependent incorporation of tea catechins, (-)-epigallocatechin-3-gallate and (-)-epigallocatechin, into human plasma.
    Nakagawa K; Okuda S; Miyazawa T
    Biosci Biotechnol Biochem; 1997 Dec; 61(12):1981-5. PubMed ID: 9438978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and antioxidant activity of green tea extract enriched in epigallocatechin (EGC) and epigallocatechin gallate (EGCG).
    Hu J; Zhou D; Chen Y
    J Agric Food Chem; 2009 Feb; 57(4):1349-53. PubMed ID: 19182914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and Biological Testing of Novel Glucosylated Epigallocatechin Gallate (EGCG) Derivatives.
    Zhang X; Wang J; Hu JM; Huang YW; Wu XY; Zi CT; Wang XJ; Sheng J
    Molecules; 2016 May; 21(5):. PubMed ID: 27187321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications.
    Singh BN; Shankar S; Srivastava RK
    Biochem Pharmacol; 2011 Dec; 82(12):1807-21. PubMed ID: 21827739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of the tea polyphenol epigallocatechin-3-gallate encapsulated in targeted vesicles after intravenous administration.
    Lemarié F; Chang CW; Blatchford DR; Amor R; Norris G; Tetley L; McConnell G; Dufès C
    Nanomedicine (Lond); 2013 Feb; 8(2):181-92. PubMed ID: 22891867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photochemoprevention of ultraviolet Beam Radiation-induced DNA damage in keratinocytes by topical delivery of nanoformulated Epigallocatechin-3-gallate.
    Salaheldin TA; Adhami VM; Fujioka K; Mukhtar H; Mousa SA
    Nanomedicine; 2022 Aug; 44():102580. PubMed ID: 35768037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Green tea polyphenol epigallocatechin-3-gallate suppresses melanoma growth by inhibiting inflammasome and IL-1β secretion.
    Ellis LZ; Liu W; Luo Y; Okamoto M; Qu D; Dunn JH; Fujita M
    Biochem Biophys Res Commun; 2011 Oct; 414(3):551-6. PubMed ID: 21982776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigallocatechin gallate as a nutraceutical to potentially target the metabolic syndrome: novel insights into therapeutic effects beyond its antioxidant and anti-inflammatory properties.
    Ntamo Y; Jack B; Ziqubu K; Mazibuko-Mbeje SE; Nkambule BB; Nyambuya TM; Mabhida SE; Hanser S; Orlando P; Tiano L; Dludla PV
    Crit Rev Food Sci Nutr; 2024; 64(1):87-109. PubMed ID: 35916835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives.
    Nagle DG; Ferreira D; Zhou YD
    Phytochemistry; 2006 Sep; 67(17):1849-55. PubMed ID: 16876833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer effects of epigallocatechin-3-gallate nanoemulsion on lung cancer cells through the activation of AMP-activated protein kinase signaling pathway.
    Chen BH; Hsieh CH; Tsai SY; Wang CY; Wang CC
    Sci Rep; 2020 Mar; 10(1):5163. PubMed ID: 32198390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (-)-Epigallocatechin-3-gallate (EGCG) sensitizes melanoma cells to interferon induced growth inhibition in a mouse model of human melanoma.
    Nihal M; Ahsan H; Siddiqui IA; Mukhtar H; Ahmad N; Wood GS
    Cell Cycle; 2009 Jul; 8(13):2057-63. PubMed ID: 19502799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-hyperuricemic effect of epigallocatechin-3-gallate (EGCG) on hyperuricemic mice.
    Zhu C; Xu Y; Liu ZH; Wan XC; Li DX; Tai LL
    Biomed Pharmacother; 2018 Jan; 97():168-173. PubMed ID: 29091862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.